CD4/cd8 double negative mycosis fungoides with PD-1 (CD279) expression-A disease of follicular helper t-cells?

American Journal of Dermatopathology

Volumn 34, Issue 7, 2012, Pages 757-761

  Kempf, Werner ^a,b   Kazakov, Dmitry V ^c   Cipolat, Claudio ^d   Kutzner, Heinz ^e   Roncador, Giovanna ^f   Tomasini, Dario ^g  

^a Histologische Diagnostik   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c CHARLES UNIVERSITY   (Czech Republic)

^d Dermatology Practice   (Switzerland)

^e Dermatopathologische Gemeinschaftspraxis   (Germany)

^f Structural Biology and Biocomputing Programme   (Spain)

^g BUSTO ARSIZIO HOSPITAL   (Italy)

Author keywords

CD8; cutaneous T cell lymphoma; mycosis fungoides; PD 1

Indexed keywords

MOMETASONE FUROATE; PROGRAMMED DEATH 1 RECEPTOR;

AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DENATURING GRADIENT GEL ELECTROPHORESIS; ERYTHEMA; FAMILY HISTORY; FEMALE; HELPER CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHATIC LEUKEMIA; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; STEROID THERAPY; ULTRAVIOLET B RADIATION; UNSPECIFIED SIDE EFFECT;

AGED; ANTIGENS, CD4; ANTIGENS, CD8; BIOPSY; FEMALE; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MYCOSIS FUNGOIDES; PROGRAMMED CELL DEATH 1 RECEPTOR; SKIN NEOPLASMS; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR MARKERS, BIOLOGICAL;

EID: 84866743861     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31825b26d1     Document Type: Article

References (28)

1. Kazakov DV, Burg G, Kempf W. Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol. 2004;18:397-415.
2. Kempf W, Sander CA. Classification of cutaneous lymphomas-an update. Histopathology. 2011;56:57-70.
3. Hodak E, David M, Maron L, et al. CD4/CD8 double-negative epider-motropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides. J Am Acad Dermatol. 2006;55:276-284.
4. Riley JL. PD-1 signaling in primary T cells. Immunol Rev. 2009;229: 114-125.
5. Chtanova T, Tangye SG, Newton R, et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol. 2004;173:68-78.
6. Rodriguez Pinilla SM, Roncador G, Rodriguez-Peralto JL, et al. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol. 2009;33:81-90.
7. de Leval L, Rickman DS, Thielen C, et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood. 2007;109:4952-4963.
8. Roncador G, Verdes-Montenegro JF, Tedoldi S, et al. Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica. 2007;92: 1059-1066.
9. Kneba M, Bolz I, Linke B, et al. Characterization of clone-specific rearrangement T-cell receptor gamma-chain genes in lymphomas and leukemias by the polymerase chain reaction and DNA sequencing. Blood. 1994;84:574-581.
10. Wood GS, Weiss LM, Hu CH, et al. T-cell antigen deficiencies and clonal rearrangements of T-cell receptor genes in pagetoid reticulosis (Woringer-Kolopp disease). N Engl J Med. 1988;318:164-167.
11. Mielke V, Wolff HH, Winzer M, et al. Localized and disseminated pagetoid reticulosis. Diagnostic immunophenotypical findings. Arch Dermatol. 1989;125:402-406.
12. Toro JR, Beaty M, Sorbara L, et al. gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study. Arch Dermatol. 2000;136:1024-1032.
13. Jones D, Vega F, Sarris AH, et al. CD4-CD8-"Double-negative" cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course. Am J Surg Pathol. 2002;26:225-231.
14. Shimauchi T, Kabashima K, Nakashima D, et al. Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia/lymphoma. Int J Cancer. 2007;121: 2585-2590.
15. Mourtzinos N, Puri PK, Wang G, et al. CD4/CD8 double negative pagetoid reticulosis: a case report and literature review. J Cutan Pathol. 2009;37:491-496.
16. Ralfkiaer E, Wollf-Sneedorff A, Thomsen K, et al. Immunophenotypic studies in cutaneous T-cell lymphomas: clinical implications. Br J Dermatol. 1993;129:655-659.
17. Fierro MT, Novelli M, Savoia P, et al. CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients. J Cutan Pathol. 2001;28:356-362.
18. Ralfkiaer E. Controversies and discussion on early diagnosis of cutaneous T-cell lymphoma phenotyping. Dermatol Clin. 1994;12:329-334.
19. Massone C, Crisman G, Kerl H, et al. The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality. Br J Dermatol. 2008;159:881-886.
20. Edinger JT, Clark BZ, Pucevich BE, et al. CD30 expression and pro-liferative fraction in nontransformed mycosis fungoides. Am J Surg Pathol. 2009;33:1860-1868.
21. Kim EJ, Lin J, Junkins-Hopkins JM, et al. Mycosis fungoides and sezary syndrome: an update. Curr Oncol Rep. 2006;8:376-386.
22. Wada DA, Wilcox RA, Harrington SM, et al. Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sezary syndrome. Am J Hematol. 2011;86:325-327.
23. Cetinözman F, Jansen PM, Willemze R. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleo-morphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma. Am J Surg Pathol. 2012;36:109-116.
24. Kantekure K, Yang Y, Raghunath P, et al. Expression patterns of the immunosuppressive proteins PD-1/CD279 and PD-L1/CD274 at different stages of cutaneous T-cell lymphoma/mycosis fungoides. Am J Dermatopathol. 2012;34:126-128.
25. Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev. 2010;236:219-242.
26. Xerri L, Chetaille B, Serriari N, et al. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Hum Pathol. 2008;39: 1050-1058.
27. Sakthivel P, Gereke M, Bruder D. Therapeutic intervention in cancer and chronic viral infections: antibody mediated manipulation of PD-1/PD-L1 interaction. Rev Recent Clin Trials. 2012;7: 10-23.
28. Kazakov DV, Belousova IE, Kacerovska D, et al. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphoma-tous folliculitis and overt lymphomas. Am J Surg Pathol. 2008;32: 1468-1478.